taxonomy (1)
protein (1)
source (2)
structure (0)
composition (9)
disease (1)
reference (3)
site (3)
peptide (8)
- Homo sapiens (Human)
Taxonomy
Reported structure
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:5 NeuAc:2 (avg mass : 2265.0757 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
Composition
- Cancer, breast (DOID:1612)
Disease
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
Reference
- Complement factor b / Homo sapiens
Reported glycosite
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement factor b / Homo sapiens
- SPYYNVSDEISFHCYDGYTIR (21aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement factor b / Homo sapiens
- SPYYNVSDEISFHCYDGYTIR (21aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement factor b / Homo sapiens
- SPYYNVSDEISFHCYDGYTIR (21aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement factor b / Homo sapiens
- SPYYNVSDEISFHCYDGYTIR (21aa)
- IVIDPSGSMNIYIVIDGSDSIGASNFTGAK (30aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked (avg mass : 1949.7927)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement factor b / Homo sapiens
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement factor b / Homo sapiens
- IVIDPSGSMNIYIVIDGSDSIGASNFTGAK (30aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Complement factor b / Homo sapiens
- SPYYNVSDEISFHCYDGYTIR (21aa)
- IVLDPSGSMNIYLVLDGSDSIGASNFTGAKK (31aa)
- KIVLDPSGSMNIYLVLDGSDSIGASNFTGAK (31aa)
- VLDGSDSIGASNFTGAK (17aa)
- LVLDGSDSIGASNFTGAK (18aa)
- IVIDPSGSMNIYIVIDGSDSIGASNFTGAK (30aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement factor b / Homo sapiens
- IVLDPSGSMNIYLVLDGSDSIGASNFTGAKK (31aa)
- IVIDPSGSMNIYIVIDGSDSIGASNFTGAK (30aa)
- ALQAVYSMMSWPDDVPPEGWNR (22aa)
-
- Hex:4 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2265.0757)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Complement factor b / Homo sapiens
- IYLVLDGSDSIGASNFTGAK (20aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
